SEC 13F Intelligence

Managers / Q3 2025 · view latest →

Scientech Research LLC

CIK 0002011556 · 30 MONTGOMERY ST, SUITE 310, JERSEY CITY, NJ, 07302 · 201-253-5141

Reported Value
$287M
Q3 2025
Positions
550
Filings on Record
10
2019–present window
Filed
Nov 14, 2025
original filing

Summary

Scientech Research LLC reported $287M in U.S.-listed holdings across 550 positions for Q3 2025.

Compared with Q2 2025, the fund opened 349 new positions and exited 371.

Portfolio Metrics

Turnover
+53.7%
vs prior filed quarter
Top-10 Concentration
+6.4%
share of reported value
Largest Position
+0.8%
Microsoft
New / Exited
349 / 371
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’23: $100MQ4 ’23Q1 ’24: $189MQ2 ’24: $485MQ2 ’24Q3 ’24: $502MQ4 ’24: $353MQ4 ’24Q1 ’25: $378MQ2 ’25: $409MQ2 ’25Q3 ’25: $287MQ4 ’25: $159MQ4 ’25Q1 ’26: $120Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 82.1%Other: 9.6%ADR: 3.8%ETP: 2.3%REIT: 2.2%
  • Common Stock · 82.1% · $236M
  • Other · 9.6% · $27M
  • ADR · 3.8% · $11M
  • ETP · 2.3% · $7M
  • REIT · 2.2% · $6M

Quarter-over-Quarter Changes full breakdown →

vs Q2 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
NVDANVIDIA CORPORATIONNEW+10.7K10.7K+$2M$2M
LLYELI LILLY & CONEW+2.5K2.5K+$2M$2M
ALNYALNYLAM PHARMACEUTICALS INCNEW+3.9K3.9K+$2M$2M
TLRYEURTILRAY BRANDS INCNEW+1.01M1.01M+$2M$2M
UNIQURE NVNEW+29.3K29.3K+$2M$2M
MDBMONGODB INCNEW+5.5K5.5K+$2M$2M
ZBRAZEBRA TECHNOLOGIES CORPORATINEW+5.1K5.1K+$2M$2M
GRANITESHARES ETF TRNEW+15.6K15.6K+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q3 2025

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1MSFTMICROSOFT CORPCOM0.76%$2M4.2K
2NVDANVIDIA CORPORATIONCOM0.69%$2M10.7K
3APPAPPLOVIN CORPCOM CL A0.68%$2M2.7K
4LLYELI LILLY & COCOM0.68%$2M2.5K
5REGNREGENERON PHARMACEUTICALSCOM0.63%$2M3.2K
6ALNYALNYLAM PHARMACEUTICALS INCCOM0.62%$2M3.9K
7TLRYEURTILRAY BRANDS INCCOM0.61%$2M1.01M
8UNIQURE NVSHS0.60%$2M29.3K
9MDBMONGODB INCCL A0.59%$2M5.5K
10PODDINSULET CORPCOM0.54%$2M5.0K
11TRANSOCEAN LTDREGISTERED SHS0.54%$2M493.7K
12ZBRAZEBRA TECHNOLOGIES CORPORATICL A0.53%$2M5.1K
13HOODROBINHOOD MKTS INCCOM CL A0.53%$2M10.6K
14GRANITESHARES ETF TR2X LONG NVDA DAI0.51%$1M15.6K
15ADBEADOBE INCCOM0.51%$1M4.1K
16AGFIRST MAJESTIC SILVER CORPCOM0.50%$1M116.9K
17UAOSTERLING INFRASTRUCTURE INCCOM0.49%$1M4.2K
18PTCPTC INCCOM0.49%$1M6.9K
19ROPROPER TECHNOLOGIES INCCOM0.48%$1M2.7K
20VRSNVERISIGN INCCOM0.47%$1M4.8K
21CRWVCOREWEAVE INCCOM CL A0.46%$1M9.7K
22NTRANATERA INCCOM0.46%$1M8.3K
23WULFTERAWULF INCCOM0.46%$1M116.3K
24UTHUNITED THERAPEUTICS CORP DELCOM0.46%$1M3.1K
25LULULULULEMON ATHLETICA INCCOM0.46%$1M7.4K
26BEBLOOM ENERGY CORPCOM CL A0.46%$1M15.5K
27INTUINTUITCOM0.45%$1M1.9K
28DASHDOORDASH INCCL A0.45%$1M4.7K
29HDHOME DEPOT INCCOM0.44%$1M3.1K
30DOVDOVER CORPCOM0.41%$1M7.0K
31NSYNICE LTDSPONSORED ADR0.40%$1M8.0K
32MKTXMARKETAXESS HLDGS INCCOM0.40%$1M6.6K
33NNENANO NUCLEAR ENERGY INCCOM0.39%$1M28.9K
34UNHUNITEDHEALTH GROUP INCCOM0.38%$1M3.2K
35SBACSBA COMMUNICATIONS CORP NEWCL A0.38%$1M5.7K
36NETCLOUDFLARE INCCL A COM0.38%$1M5.1K
37NVONOVO-NORDISK A SADR0.38%$1M19.6K
38EATBRINKER INTL INCCOM0.38%$1M8.6K
39SFMSPROUTS FMRS MKT INCCOM0.38%$1M10.0K
40GRAB HOLDINGS LIMITEDCLASS A ORD0.37%$1M177.1K
41HCAHCA HEALTHCARE INCCOM0.36%$1M2.4K
42SPGIS&P GLOBAL INCCOM0.35%$1M2.1K
43VRTXVERTEX PHARMACEUTICALS INCCOM0.35%$1M2.6K
44CHRDCHORD ENERGY CORPORATIONCOM NEW0.35%$1M10.1K
45A4SAMERIPRISE FINL INCCOM0.35%$995,7642.0K
46DEDEERE & COCOM0.34%$975,3362.1K
47LNGCHENIERE ENERGY INCCOM NEW0.33%$941,8004.0K
48RAREULTRAGENYX PHARMACEUTICAL INCOM0.33%$941,65431.3K
49SANMSANMINA CORPORATIONCOM0.33%$941,6008.2K
50CSLCARLISLE COS INCCOM0.33%$936,5492.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$120M449May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$159M479Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$287M550Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$409M572Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$378M541May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$353M550Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$502M590Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$485M563Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$189M394May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$100M310Feb 14, 202413F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.